Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Paul Foster

17beta-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer.

scientific article published on May 2008

1H NMR-MS-based heterocovariance as a drug discovery tool for fishing bioactive compounds out of a complex mixture of structural analogues

scientific article published on 31 July 2019

A comparative study of the ability of calcitonin gene-related peptide and adrenomedullin(13 - 52) to modulate microvascular but not thermal hyperalgesia responses

scientific article

A new micronized formulation of 2-methoxyestradiol-bis-sulfamate (STX140) is therapeutically potent against breast cancer.

scientific article

A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor

scientific article

Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography

scientific article

Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment.

scholarly article

BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure.

scientific article published on 20 January 2009

C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression

scientific article

Chimeric microtubule disruptors

scientific article

Design, synthesis, and biological evaluation of new arylamide derivatives possessing sulfonate or sulfamate moieties as steroid sulfatase enzyme inhibitors

scientific article published on 22 April 2016

Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.

scientific article published on 22 August 2008

Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer

scientific article published on 4 October 2007

Endothelial cells play an essential role in the thermal hyperalgesia induced by nerve growth factor.

scientific article

Estrogen Activation by Steroid Sulfatase Increases Colorectal Cancer Proliferation via GPER.

scientific article

Estrone Sulfate Transport and Steroid Sulfatase Activity in Colorectal Cancer: Implications for Hormone Replacement Therapy

scientific article published on 07 March 2017

In touch with your feminine side: how oestrogen metabolism impacts prostate cancer

scientific article

In vivo and in vitro properties of STX2484: a novel non-steroidal anti-cancer compound active in taxane-resistant breast cancer

scientific article

In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy

scientific article published in September 2006

In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol

scientific article published on 10 April 2007

NNT is a key regulator of adrenal redox homeostasis and steroidogenesis in male mice.

scientific article published on 18 October 2017

Oestrogen and colorectal cancer: mechanisms and controversies ⬇️

scientific article published on January 15, 2013

Recent developments of steroid sulfatase inhibitors as anti-cancer agents.

scientific article published on October 2008

STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells.

scientific article published on January 2008

STX140, but not paclitaxel, inhibits mammary tumour initiation and progression in C3(1)/SV40 T/t-antigen transgenic mice

scientific article (publication date: 2013)

STX2171, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, is efficacious in vivo in a novel hormone-dependent prostate cancer model

scientific article published on 18 February 2013

Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers

scientific article

Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents

scientific article

The In Vitro and In Vivo Activity of the Microtubule Disruptor STX140 Is Mediated by Hif-1 Alpha and CAIX Expression

scientific article

The Regulation of Steroid Action by Sulfation and Desulfation

scientific article

The development of steroid sulfatase inhibitors for hormone-dependent cancer therapy

scientific article published on February 2009

The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancer.

scientific article published on 07 October 2008

The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers

scientific article published on 20 November 2007

The use of steroid sulfatase inhibitors as a novel therapeutic strategy against hormone-dependent endometrial cancer

scientific article published on May 2008

Paulina is supported by:

About Paulina

Help